Clinical studies on patients with CRC suggest that VEGF-A expression is significantly higher in metastatic tumors than in non metastatic tumors, and the increased VEGF-A expression is related to the worse prognosis [41]. This evidence concerns the gene VEGFA and metastatic neoplasm.